Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 101620, 3 pages
http://dx.doi.org/10.1155/2014/101620
Editorial

Perinatal Pharmacology

1Department of Development and Regeneration, KU Leuven and Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
2Department of Surgery, Section of Neonatal Intensive Care Unit, Puericulture Institute and Neonatal Section, University of Cagliari, Cagliari, Italy
3Departments of Pediatrics, Pharmacology, Physiology, and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington DC, USA
4Intensive Care, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
5Department of Pediatric Pharmacology, University Children's Hospital Basel, Basel, Switzerland
6Department of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University of Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany

Received 19 February 2014; Accepted 19 February 2014; Published 13 April 2014

Copyright © 2014 Karel Allegaert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. N. Feghali and D. R. Mattison, “Clinical therapeutics in pregnancy,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 783528, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Allegaert, J. P. Langhendries, and J. N. van den Anker, “Educational paper: do we need neonatal clinical pharmacologists?” European Journal of Pediatrics, vol. 172, no. 4, pp. 429–435, 2013. View at Publisher · View at Google Scholar
  3. F. Khalil and S. Läer, “Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 907461, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. F. de Cock, C. Piana, E. H. Krekels, M. Danhof, K. Allegaert, and C. A. Knibbe, “The role of population PK-PD modelling in paediatric clinical research,” European Journal of Clinical Pharmacology, vol. 67, no. 1, supplement, pp. 5–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Allegaert, A. Smits, and J. van den Anker, “Physiologically based pharmacokinetic modeling in pediatric drug development: a clinician's request for a more integrated approach,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 103763, 3 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. C. van Hasselt, B. Green, and G. A. Morrish, “Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women,” Pharmaceutical Research, vol. 29, no. 6, pp. 1609–1617, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Allegaert, J. N. van den Anker, J. N. de Hoon et al., “Covariates of tramadol disposition in the first months of life,” British Journal of Anaesthesia, vol. 100, no. 4, pp. 525–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Wachman, M. J. Hayes, M. S. Brown et al., “Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome,” Journal of the American Medical Association, vol. 309, no. 17, pp. 1821–1817, 2013. View at Publisher · View at Google Scholar